The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

R.W. Rapkins, F. Wang, H.T.N. Nguyen, T.F. Cloughesy, A. Lai, W. Ha, Anna Nowak, M.P. Hitchins, K.L. Mcdonald

Research output: Contribution to journal › Article

37 Citations (Scopus)

Cite this

@article{15f08b0b1a7b4453b7149bf5381c0fe5,

title = "The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide",

author = "R.W. Rapkins and F. Wang and H.T.N. Nguyen and T.F. Cloughesy and A. Lai and W. Ha and Anna Nowak and M.P. Hitchins and K.L. Mcdonald",

year = "2015",

doi = "10.1093/neuonc/nov064",

language = "English",

volume = "17",

pages = "1589--1598",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

AU - Rapkins, R.W.

AU - Wang, F.

AU - Nguyen, H.T.N.

AU - Cloughesy, T.F.

AU - Lai, A.

AU - Ha, W.

AU - Nowak, Anna

AU - Hitchins, M.P.

AU - Mcdonald, K.L.

PY - 2015

Y1 - 2015

U2 - 10.1093/neuonc/nov064

DO - 10.1093/neuonc/nov064

M3 - Article

C2 - 25910840

VL - 17

SP - 1589

EP - 1598

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 12

ER -